Skip to content
Brand AI

Caplin Steriles Limited

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Caplin Point acquires 10 approved ANDAs for injectable and ophthalmic products

    Caplin Point Laboratories, through subsidiaries Caplin Steriles Limited and Caplin One Labs Limited, acquired 10 approved Abbreviated New Drug Applications for injectable and ophthalmic products from a leading multinational generic product manufacturing company, with an addressable market of $473.2 million for the 12 months ending August 2025.

    Source